Doman, Jordan L. http://orcid.org/0000-0002-9887-0391
Raguram, Aditya
Newby, Gregory A. http://orcid.org/0000-0001-7869-2615
Liu, David R. http://orcid.org/0000-0002-9943-7557
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U01 AI142756)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG009490)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
Howard Hughes Medical Institute (Liu investigatorship)
Article History
Received: 24 November 2019
Accepted: 7 January 2020
First Online: 10 February 2020
Competing interests
: D.R.L. is a consultant and cofounder of Editas Medicine, Pairwise Plants, Beam Therapeutics and Prime Medicine, companies that use genome editing. J.L.D., A.R. and D.R.L. through the Broad Institute have filed patent applications on aspects of this work.